Sökning: onr:"swepub:oai:DiVA.org:uu-350272" >
Long-term safety an...
Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer
-
- Matikas, Alexios (författare)
- Karolinska Institutet
-
- Margolin, Sara (författare)
- Karolinska Institutet
-
- Hellström, Mats (författare)
- Karolinska Univ Hosp, Radiumhemmet, Dept Oncol, Stockholm, Sweden.
-
visa fler...
-
- Johansson, Hemming (författare)
- Karolinska Institutet
-
- Bengtsson, Nils-Olof (författare)
- Norrland Univ Hosp, Umea, Sweden.
-
- Karlsson, Lena (författare)
- Cty Hosp, Sundsvall, Sweden.
-
- Edlund, Per (författare)
- Gavle Cent Hosp, Gavle, Sweden.
-
- Karlsson, Per, 1963 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för onkologi,Institute of Clinical Sciences, Department of Oncology
-
- Lidbrink, Elisabet (författare)
- Karolinska Univ Hosp, Radiumhemmet, Dept Oncol, Stockholm, Sweden.
-
- Linderholm, Barbro, 1959 (författare)
- Gothenburg University,Göteborgs universitet,Karolinska Institutet,Institutionen för kliniska vetenskaper, Avdelningen för onkologi,Institute of Clinical Sciences, Department of Oncology
-
- Lindman, Henrik (författare)
- Uppsala universitet,Experimentell och klinisk onkologi
-
- Malmstrom, Per (författare)
- Skane Univ Hosp, Dept Oncol & Radiat Phys, Lund, Sweden.
-
- Villman, Kenneth (författare)
- Orebro Univ Hosp, Orebro, Sweden.
-
- Foukakis, Theodoros (författare)
- Karolinska Institutet
-
- Bergh, Jonas (författare)
- Karolinska Institutet
-
visa färre...
-
Karolinska Institutet Karolinska Univ Hosp, Radiumhemmet, Dept Oncol, Stockholm, Sweden (creator_code:org_t)
- 2017-11-30
- 2018
- Engelska.
-
Ingår i: Breast Cancer Research and Treatment. - : SPRINGER. - 0167-6806 .- 1573-7217. ; 168:2, s. 349-355
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://uu.diva-port... (primary) (Raw object)
-
https://link.springe...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
https://gup.ub.gu.se...
-
visa färre...
Abstract
Ämnesord
Stäng
- Although adjuvant polychemotherapy improves outcomes for early breast cancer, the significant variability in terms of pharmacokinetics results in differences in efficacy and both short and long-term toxicities. Retrospective studies support the use of dose tailoring according to the hematologic nadirs. The SBG 2004-1 trial was a randomized feasibility phase II study which assessed tailored dose-dense epirubicin and cyclophosphamide (EC) followed by docetaxel (T) (group A), the same regimen with fixed doses (group B) and the TAC regimen (group C). Women aged 18-65 years, ECOG PS 0-1 with at least one positive axillary lymph node were randomized 1:1:1. The primary endpoint of the study was the safety and feasibility of the treatment. Toxicity was graded according to CTC-AE version 3.0. The design and short-term toxicity have been previously published. Here, we report safety and efficacy data after 10 years of follow-up. A total of 124 patients were included in the study. After a median follow-up of 10.3 years, the probability for 10-year survival was 78.5, 75.1, and 63.4% and for relapse free survival 64.1, 71.0, and 59.5% for groups A, B, and C, respectively. There were no cases of clinically diagnosed cardiotoxicity or hematologic malignancies. No patient was lost to follow-up. In this randomized phase II trial, tailored dose adjuvant chemotherapy was feasible, without an increased risk for long-term adverse events after a median follow-up of 10 years.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- Adjuvant chemotherapy
- Breast cancer
- Dose-dense
- Randomized
- Tailored dose
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Matikas, Alexios
-
Margolin, Sara
-
Hellström, Mats
-
Johansson, Hemmi ...
-
Bengtsson, Nils- ...
-
Karlsson, Lena
-
visa fler...
-
Edlund, Per
-
Karlsson, Per, 1 ...
-
Lidbrink, Elisab ...
-
Linderholm, Barb ...
-
Lindman, Henrik
-
Malmstrom, Per
-
Villman, Kenneth
-
Foukakis, Theodo ...
-
Bergh, Jonas
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
Breast Cancer Re ...
- Av lärosätet
-
Uppsala universitet
-
Karolinska Institutet
-
Göteborgs universitet